Lenzing Biocel Paskov made a net profit of CZK 1,111 mil in 2019, down 21.6% compared to the previous year. Total sales reached CZK 5,285 mil, which is up 0.683% when compared to the previous year.
Historically, between 2007 and 2019, the company’s net profit reached a high of CZK 1,621 mil in 2017 and a low of CZK -99.0 mil in 2012. Over the last decade the firm's net profit increased by an average of 0% a year.
Sales have grown by 5.42% a year on average since 2009. They reached a high of CZK 5,618 mil in 2015 and a low of CZK 3,119 mil in 2009.
The company has been operating with an average EBITDA margin of 37.8% in the last 5 years and average net margin of 24.0%. The firm generated an average return on invested capital of 22.4% for its shareholders over the last five years.
You can see all the company’s data at Lenzing Biocel Paskov profile, or you can download a report on the company in the report section.
Helgi Library 
